USS Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.3M Buy
970,841
+22,335
+2% +$595K 0.11% 101
2025
Q4
$23.6M Hold
948,506
0.11% 110
2025
Q3
$24.2M Hold
948,506
0.11% 107
2025
Q2
$23M Buy
948,506
+14,392
+2% +$336K 0.14% 96
2025
Q1
$23.7M Sell
934,114
-1,024,400
-52% -$26.8M 0.17% 88
2024
Q4
$52M Sell
1,958,514
-65,118
-3% -$1.77M 0.36% 50
2024
Q3
$58.6M Hold
2,023,632
0.43% 40
2024
Q2
$56.6M Buy
2,023,632
+257,724
+15% +$7.1M 0.45% 35
2024
Q1
$49M Buy
1,765,908
+54,769
+3% +$1.52M 0.4% 41
2023
Q4
$49.3M Buy
1,711,139
+56,920
+3% +$1.72M 0.44% 37
2023
Q3
$54.9M Buy
1,654,219
+43,949
+3% +$1.55M 0.59% 32
2023
Q2
$59.1M Buy
1,610,270
+154,861
+11% +$6.03M 0.7% 25
2023
Q1
$59.4M Buy
1,455,409
+33,845
+2% +$1.46M 0.81% 23
2022
Q4
$72.9M Sell
1,421,564
-142,256
-9% -$6.82M 1.02% 11
2022
Q3
$68.6M Sell
1,563,820
-415,236
-21% -$20.2M 1% 10
2022
Q2
$104M Sell
1,979,056
-218,055
-10% -$11.1M 1.04% 11
2022
Q1
$114M Buy
2,197,111
+71,693
+3% +$3.72M 0.93% 12
2021
Q4
$125M Sell
2,125,418
-3,300
-0.2% -$164K 0.95% 12
2021
Q3
$91.5M Buy
2,128,718
+218,977
+11% +$9.7M 0.77% 17
2021
Q2
$74.8M Buy
1,909,741
+5,100
+0.3% +$198K 0.59% 47
2021
Q1
$69M Hold
1,904,641
0.6% 44
2020
Q4
$70.1M Sell
1,904,641
-157,342
-8% -$5.77M 0.64% 40
2020
Q3
$71.8M Hold
2,061,983
0.69% 36
2020
Q2
$64M Buy
2,061,983
+649,681
+46% +$22.1M 0.67% 41
2020
Q1
$43.7M Buy
1,412,302
+983,429
+229% +$33.5M 0.6% 51
2019
Q4
$15.9M Buy
428,873
+175,281
+69% +$6.24M 0.16% 95
2019
Q3
$8.64M Hold
253,592
0.09% 118
2019
Q2
$10.4M Sell
253,592
-11,489
-4% -$456K 0.11% 110
2019
Q1
$10.7M Hold
265,081
0.12% 93
2018
Q4
$11M Sell
265,081
-25,507
-9% -$1.06M 0.14% 81
2018
Q3
$12.2M Hold
290,588
0.12% 79
2018
Q2
$10M Hold
290,588
0.11% 87
2018
Q1
$10.1M Buy
290,588
+95,282
+49% +$3.28M 0.11% 94
2017
Q4
$6.72M Buy
+195,306
New +$6.66M 0.08% 113
2017
Q2
Sell
-186,980
Closed -$6.07M 155
2017
Q1
$6.07M Buy
186,980
+16,759
+10% +$528K 0.08% 106
2016
Q4
$5.25M Hold
170,221
0.08% 126
2016
Q3
$5.47M Buy
+170,221
New +$5.69M 0.08% 127
2016
Q1
Sell
-2,909,631
Closed -$89.1M 144
2015
Q4
$89.1M Hold
2,909,631
1.47% 27
2015
Q3
$86.7M Hold
2,909,631
1.54% 25
2015
Q2
$92.6M Hold
2,909,631
1.47% 29
2015
Q1
$96M Hold
2,909,631
1.57% 25
2014
Q4
$86M Hold
2,909,631
1.41% 31
2014
Q3
$81.6M Sell
2,909,631
-252,960
-8% -$7.1M 1.43% 30
2014
Q2
$89.1M Hold
3,162,591
1.53% 27
2014
Q1
$96.4M Hold
3,162,591
1.74% 16
2013
Q4
$91.6M Hold
3,162,591
1.76% 17
2013
Q3
$86.2M Hold
3,162,591
1.61% 17
2013
Q2
$84M Buy
+3,162,591
New +$87.4M 1.79% 12

Other funds holding PFE

USS Investment Management's PFE Position: Q1 2026 in Review

USS Investment Management increased its Pfizer (PFE) stake by 2.4% in Q1 2026, buying an estimated $595K and bringing the position to 970,841 shares worth $27.3M. The position accounts for 0.11% of the portfolio, ranked #101.

USS Investment Management first reported a position in PFE in Q2 2013 and has held it in 48 quarters since. The position peaked at $125M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • USS Investment Management held 970,841 shares of Pfizer worth $27.3M as of Q1 2026.
  • USS Investment Management bought 22,335 Pfizer shares in Q1 2026, an estimated $595K.
  • Pfizer made up 0.11% of USS Investment Management's portfolio in Q1 2026, its #101 holding.
  • USS Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 48 quarters since.
  • USS Investment Management's Pfizer position peaked at $125M in Q4 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on USS Investment Management's 13F filing for Q1 2026, filed 24 Apr 2026.